Hosted on MSN7h
While Rare, a Disease Linked to Vision Loss Could Develop for Ozempic Users
Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.
Some patients want to take a holiday pause on weight-loss drugs. Here's what doctors say
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
Hosted on MSN11h
Ozempic for Alzheimer's? What Drives Brain Age; Primary Care Alzheimer's Guideline
Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
Authorized generics are the exact copies of branded drugs, sold by another company with the branded drug manufacturer’s ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
Health.com1d
Ozempic May Be Linked to Cause of Sudden Blindness, Another Study Shows
Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...
Everyday Health1d
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
WW International Needs To Go On A Debt Reduction Diet To Survive
Financial analyst assesses the credit market concerns and declining operating results for WW International, with insight on ...
Yahoo4d
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
The experimental drug puts semaglutide, the ingredient in Ozempic and the weight-loss drug Wegovy, together with a medicine ...
pharmaphorum15d
Novo completes major filings for blockbuster hope semaglutide
Novo Nordisk has its weekly diabetes hopeful semaglutide filed in five key markets, after submitting a dossier in Japan. Novo has just filed semaglutide, a new glucagon-like peptide (GLP-1 ...